社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
ToTheMOON
IP属地:未知
+关注
帖子 · 590
帖子 · 590
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
ToTheMOON
ToTheMOON
·
2021-12-19
Yup lol I
Novavax, Vir among healthcare gainers, Pfizer posts best rally in a decade
The healthcare stocks in the S&P 500 outperformed all other sectors in the broader index with a ~2.5
Novavax, Vir among healthcare gainers, Pfizer posts best rally in a decade
看
1,673
回复
1
点赞
7
编组 21备份 2
分享
举报
ToTheMOON
ToTheMOON
·
2021-12-18
Yup I just bought
Novavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emergency use list
Novavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emerg
Novavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emergency use list
看
1,531
回复
1
点赞
5
编组 21备份 2
分享
举报
ToTheMOON
ToTheMOON
·
2021-12-17
Search warrior shoes
Top 10 Meme Stocks of 2021 and How They’ll Fare in 2022
It's time to decide which of these meme stocks are good investments Source: Michael Vi / Shutterstoc
Top 10 Meme Stocks of 2021 and How They’ll Fare in 2022
看
2,462
回复
评论
点赞
2
编组 21备份 2
分享
举报
ToTheMOON
ToTheMOON
·
2021-12-16
I just bought
非常抱歉,此主贴已删除
看
1,681
回复
1
点赞
3
编组 21备份 2
分享
举报
ToTheMOON
ToTheMOON
·
2021-12-16
Yup lol 😂
Motional partners with Uber to provide autonomous food deliveries in California
Motional, the self-driving joint venture of Hyundai Motor Co and Aptiv PLC, on Thursday said it was
Motional partners with Uber to provide autonomous food deliveries in California
看
1,960
回复
评论
点赞
1
编组 21备份 2
分享
举报
ToTheMOON
ToTheMOON
·
2021-12-16
Yup lol 😂 is it ok to
U.S. manufacturing activity slows; factory supply constraints easing - IHS Markit survey
U.S. manufacturing activity slowed to a one-year low in December, but there are signs that labor and
U.S. manufacturing activity slows; factory supply constraints easing - IHS Markit survey
看
1,535
回复
评论
点赞
6
编组 21备份 2
分享
举报
ToTheMOON
ToTheMOON
·
2021-12-15
You can only buy a new version
非常抱歉,此主贴已删除
看
1,667
回复
1
点赞
6
编组 21备份 2
分享
举报
ToTheMOON
ToTheMOON
·
2021-12-13
Yup lol I got it
Petros Pharmaceuticals soared nearly 50% in premarket trading as it reported positive label comprehension results for Stendra
Petros Pharmaceuticals soared nearly 50% in premarket trading as it reported positive label comprehe
Petros Pharmaceuticals soared nearly 50% in premarket trading as it reported positive label comprehension results for Stendra
看
1,565
回复
评论
点赞
1
编组 21备份 2
分享
举报
ToTheMOON
ToTheMOON
·
2021-12-12
Yup lol lol haha I was thinking 🤔
非常抱歉,此主贴已删除
看
1,791
回复
评论
点赞
9
编组 21备份 2
分享
举报
ToTheMOON
ToTheMOON
·
2021-12-11
Use my phone for every one ☝️
非常抱歉,此主贴已删除
看
2,382
回复
评论
点赞
3
编组 21备份 2
分享
举报
加载更多
暂无粉丝
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3576212227172632","uuid":"3576212227172632","gmtCreate":1613119423144,"gmtModify":1615860568398,"name":"ToTheMOON","pinyin":"tothemoon","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/7769f4b8d26aa1903d8784e79b05b4df","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":47,"headSize":6,"tweetSize":590,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.06.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.44%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":693018235,"gmtCreate":1639926427837,"gmtModify":1639926428365,"author":{"id":"3576212227172632","authorId":"3576212227172632","name":"ToTheMOON","avatar":"https://static.tigerbbs.com/7769f4b8d26aa1903d8784e79b05b4df","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576212227172632","authorIdStr":"3576212227172632"},"themes":[],"htmlText":"Yup lol I ","listText":"Yup lol I ","text":"Yup lol I","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/693018235","repostId":"1122414343","repostType":4,"repost":{"id":"1122414343","kind":"news","pubTimestamp":1639884070,"share":"https://www.laohu8.com/m/news/1122414343?lang=&edition=full","pubTime":"2021-12-19 11:21","market":"us","language":"en","title":"Novavax, Vir among healthcare gainers, Pfizer posts best rally in a decade","url":"https://stock-news.laohu8.com/highlight/detail?id=1122414343","media":"Seeking Alpha","summary":"The healthcare stocks in the S&P 500 outperformed all other sectors in the broader index with a ~2.5","content":"<p>The healthcare stocks in the S&P 500 outperformed all other sectors in the broader index with a ~2.5% gain thanks mainly to M&A prospects. <a href=\"https://laohu8.com/S/HCSG\">Healthcare</a> technology, along with names battling the resurgence of COVID-19, led the gainers while the overall index fell ~1.9%.</p>\n<p>Among stocks with more than $2B market capitalization and 100K average daily volume over the past week, <a href=\"https://laohu8.com/S/ARNA\">Arena Pharmaceuticals </a> dominated with a ~83.8% rise after <a href=\"https://laohu8.com/S/PFE\">Pfizer </a> agreed to acquire it in a ~$6.7B deal with 100% premium for the biotech. <a href=\"https://laohu8.com/S/CERN\">Cerner </a> also joined the M&A-driven rally to gain ~20.7% over the week amid reports of a potential ~$30B bid from <a href=\"https://laohu8.com/S/ORCL\">Oracle </a> for the electronic-medical-records company.</p>\n<p>Vaccine developer, <a href=\"https://laohu8.com/S/NVAX\">Novavax </a> jumped ~30.5% as investors welcomed the WHO clearance for the company’s COVID-19 shot. Further gains for the Maryland-based biotech are likely when an expert panel of the European regulators is set to review the marketing authorization for the vaccine next week.</p>\n<p><a href=\"https://laohu8.com/S/BHVN\">Biohaven Pharmaceutical </a> posted a ~25.2% weekly rise after the company announced the approval for NURTEC ODT (rimegepant) in Israel, making it the first regulatory win for the migraine drug outside the U.S. Meanwhile, Vir Biotechnology (NASDAQ:VIR) surged ~23.7% to stand among best gainers for the second week this month. More data emerged this week confirming the Omicron-neutralizing effect of the company’s COVID-19 therapy developed in partnership with GlaxoSmithKline (NYSE:GSK). Rounding out the top five gainers, <a href=\"https://laohu8.com/S/ROIV\">Roivant Sciences </a> added ~22.6%.</p>\n<p>Notable gainer: <a href=\"https://laohu8.com/S/PFE\">Pfizer</a> (PFE) made headlines throughout the week, raising its sales guidance for the COVID-19 vaccine once again as the rapidly spreading Omicron variant highlighted the need for booster shots. Despite an abrupt end to its six-day rally on Friday, the <a href=\"https://laohu8.com/S/NWY\">New York</a>-based pharma giant with a ~12.7% rise recorded its best weekly gain since March 2009.</p>\n<p>Among worst performers of the week, two newly IPO’ed biotechs, Instil Bio (NASDAQ:TIL) and Exscientia (NASDAQ:EXAI), stood out, falling 19.3% and ~13.5%, respectively, despite their favorable ratings on Wall Street. Meanwhile, GoodRx Holdings (NASDAQ:GDRX), an operator of a price comparison platform for prescription medicine slumped ~15.6%.</p>\n<p>Last week’s best performer, <a href=\"https://laohu8.com/S/BHG\">Bright Health Group</a>, crashed ~13.1%, hurt by the sole Sell rating issued by <a href=\"https://laohu8.com/S/GS\">Goldman Sachs</a> even as the investment bank kicked off its coverage on managed care with largely positive views.</p>\n<p>Allogene Therapeutics (NASDAQ:ALLO) dropped ~12.3% after the company’s ASH presentations on Phase 1 data for experimental allogeneic <a href=\"https://laohu8.com/S/00699\">CAR</a> T therapies failed to excite investors, including Cathie Wood’s Ark Investment Management, which sold ~1.6M shares of the biotech several days later.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax, Vir among healthcare gainers, Pfizer posts best rally in a decade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax, Vir among healthcare gainers, Pfizer posts best rally in a decade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-19 11:21 GMT+8 <a href=https://seekingalpha.com/news/3781487-novavax-vir-among-healthcare-gainers-pfizer-posts-best-rally-in-a-decade><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The healthcare stocks in the S&P 500 outperformed all other sectors in the broader index with a ~2.5% gain thanks mainly to M&A prospects. Healthcare technology, along with names battling the ...</p>\n\n<a href=\"https://seekingalpha.com/news/3781487-novavax-vir-among-healthcare-gainers-pfizer-posts-best-rally-in-a-decade\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://seekingalpha.com/news/3781487-novavax-vir-among-healthcare-gainers-pfizer-posts-best-rally-in-a-decade","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122414343","content_text":"The healthcare stocks in the S&P 500 outperformed all other sectors in the broader index with a ~2.5% gain thanks mainly to M&A prospects. Healthcare technology, along with names battling the resurgence of COVID-19, led the gainers while the overall index fell ~1.9%.\nAmong stocks with more than $2B market capitalization and 100K average daily volume over the past week, Arena Pharmaceuticals dominated with a ~83.8% rise after Pfizer agreed to acquire it in a ~$6.7B deal with 100% premium for the biotech. Cerner also joined the M&A-driven rally to gain ~20.7% over the week amid reports of a potential ~$30B bid from Oracle for the electronic-medical-records company.\nVaccine developer, Novavax jumped ~30.5% as investors welcomed the WHO clearance for the company’s COVID-19 shot. Further gains for the Maryland-based biotech are likely when an expert panel of the European regulators is set to review the marketing authorization for the vaccine next week.\nBiohaven Pharmaceutical posted a ~25.2% weekly rise after the company announced the approval for NURTEC ODT (rimegepant) in Israel, making it the first regulatory win for the migraine drug outside the U.S. Meanwhile, Vir Biotechnology (NASDAQ:VIR) surged ~23.7% to stand among best gainers for the second week this month. More data emerged this week confirming the Omicron-neutralizing effect of the company’s COVID-19 therapy developed in partnership with GlaxoSmithKline (NYSE:GSK). Rounding out the top five gainers, Roivant Sciences added ~22.6%.\nNotable gainer: Pfizer (PFE) made headlines throughout the week, raising its sales guidance for the COVID-19 vaccine once again as the rapidly spreading Omicron variant highlighted the need for booster shots. Despite an abrupt end to its six-day rally on Friday, the New York-based pharma giant with a ~12.7% rise recorded its best weekly gain since March 2009.\nAmong worst performers of the week, two newly IPO’ed biotechs, Instil Bio (NASDAQ:TIL) and Exscientia (NASDAQ:EXAI), stood out, falling 19.3% and ~13.5%, respectively, despite their favorable ratings on Wall Street. Meanwhile, GoodRx Holdings (NASDAQ:GDRX), an operator of a price comparison platform for prescription medicine slumped ~15.6%.\nLast week’s best performer, Bright Health Group, crashed ~13.1%, hurt by the sole Sell rating issued by Goldman Sachs even as the investment bank kicked off its coverage on managed care with largely positive views.\nAllogene Therapeutics (NASDAQ:ALLO) dropped ~12.3% after the company’s ASH presentations on Phase 1 data for experimental allogeneic CAR T therapies failed to excite investors, including Cathie Wood’s Ark Investment Management, which sold ~1.6M shares of the biotech several days later.","news_type":1,"symbols_score_info":{"ARNA":0.9,"CERN":0.9,"ORCL":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":1673,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699813240,"gmtCreate":1639776908589,"gmtModify":1639776942661,"author":{"id":"3576212227172632","authorId":"3576212227172632","name":"ToTheMOON","avatar":"https://static.tigerbbs.com/7769f4b8d26aa1903d8784e79b05b4df","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576212227172632","authorIdStr":"3576212227172632"},"themes":[],"htmlText":"Yup I just bought ","listText":"Yup I just bought ","text":"Yup I just bought","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/699813240","repostId":"1155244596","repostType":4,"repost":{"id":"1155244596","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639752003,"share":"https://www.laohu8.com/m/news/1155244596?lang=&edition=full","pubTime":"2021-12-17 22:40","market":"us","language":"en","title":"Novavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emergency use list","url":"https://stock-news.laohu8.com/highlight/detail?id=1155244596","media":"Tiger Newspress","summary":"Novavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emerg","content":"<p>Novavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emergency use list.<img src=\"https://static.tigerbbs.com/6e0b5588f7377a98c70179cdc8612b3f\" tg-width=\"765\" tg-height=\"561\" width=\"100%\" height=\"auto\">The World Health Organization has included its vaccine NVX-CoV2373 on the emergency use list,and its original drug called nuvaxovidtm is currently undergoing evaluation by the European Medicines Agency.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emergency use list</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emergency use list\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-17 22:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Novavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emergency use list.<img src=\"https://static.tigerbbs.com/6e0b5588f7377a98c70179cdc8612b3f\" tg-width=\"765\" tg-height=\"561\" width=\"100%\" height=\"auto\">The World Health Organization has included its vaccine NVX-CoV2373 on the emergency use list,and its original drug called nuvaxovidtm is currently undergoing evaluation by the European Medicines Agency.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1155244596","content_text":"Novavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emergency use list.The World Health Organization has included its vaccine NVX-CoV2373 on the emergency use list,and its original drug called nuvaxovidtm is currently undergoing evaluation by the European Medicines Agency.","news_type":1,"symbols_score_info":{"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":1531,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699088732,"gmtCreate":1639722623659,"gmtModify":1639722624202,"author":{"id":"3576212227172632","authorId":"3576212227172632","name":"ToTheMOON","avatar":"https://static.tigerbbs.com/7769f4b8d26aa1903d8784e79b05b4df","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576212227172632","authorIdStr":"3576212227172632"},"themes":[],"htmlText":"Search warrior shoes ","listText":"Search warrior shoes ","text":"Search warrior shoes","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/699088732","repostId":"1162808117","repostType":4,"repost":{"id":"1162808117","kind":"news","pubTimestamp":1639709791,"share":"https://www.laohu8.com/m/news/1162808117?lang=&edition=full","pubTime":"2021-12-17 10:56","market":"us","language":"en","title":"Top 10 Meme Stocks of 2021 and How They’ll Fare in 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=1162808117","media":"InvestorPlace","summary":"It's time to decide which of these meme stocks are good investments\nSource: Michael Vi / Shutterstoc","content":"<p>It's time to decide which of these meme stocks are good investments</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/328b1ec2a89b0b45da9884d8db54b98f\" tg-width=\"1024\" tg-height=\"576\" width=\"100%\" height=\"auto\"><span>Source: Michael Vi / Shutterstock.com</span></p>\n<p>We’re past the point of denial about meme stocks. What looked unsustainable nine months ago is proving to have staying power. Retail investors continue to identify their favorite stocks and drive up the price.</p>\n<p>The bullish case for meme stocks says that retail investors, with more research available to them than ever before, are willing to take a risk on companies that may be the next <b>Amazon</b>(NASDAQ:<b><u>AMZN</u></b>). The bearish case is that they may be propping up companies that deserve to trade for much, much lower.</p>\n<p>Who’s to say which side is right? I tend to believe that some of the moral outrage being expressed by retail investors against hedge funds is a rationale to avoid admitting that they’re investment strategy is similar to gambling. But there are many things in life that are a gamble and it’s not my money.</p>\n<p>That argument will continue to play out in 2022. So it may be interesting to look at 10 meme stocks that have been part of the this movement in 2021. And it’s also time to take a look at how these stocks may fare in 2022.</p>\n<ul>\n <li><b>GameStop</b>(NYSE:<b><u>GME</u></b>)</li>\n <li><b>AMC Entertainment</b>(NYSE:<b><u>AMC</u></b>)</li>\n <li><b>BlackBerry</b>(NYSE:<b><u>BB</u></b>)</li>\n <li><b>Clover Health</b>(NASDAQ:<b><u>CLOV</u></b>)</li>\n <li><b>Zomedica</b>(NYSE:<b><u>ZOM</u></b>)</li>\n <li><b>Sundial Growers</b>(NASDAQ:<b><u>SNDL</u></b>)</li>\n <li><b>Bed Bath & Beyond</b>(NASDAQ:<b><u>BBBY</u></b>)</li>\n <li><b>Tesla</b>(NASDAQ:<b><u>TSLA</u></b>)</li>\n <li><b>ContextLogic</b>(NASDAQ:<b><u>WISH</u></b>)</li>\n <li><b>XPresSpa</b>(NASDAQ:<b><u>XSPA</u></b>)</li>\n</ul>\n<p><b>GameStop (GME)</b></p>\n<p>GameStop is the company that made the terms “meme stocks” and “short squeeze” household names. The initial surge in GME stock was caused by retail investors who identified a high level of short interest in the stock. This led to the short squeeze to end all short squeezes. GameStop stock moved from $17.25 to a closing price of $347.51 in late January.</p>\n<p>However, a recent report from the <b>Securities & Exchange Commission</b>(SEC) confirms that the rise in the GME stock price was largely due to retail investors continuing to bid the stock higher, not as much short sellers covering their position.</p>\n<p>Needless to say, the stock price wasn’t sustainable, but GME stock is still up over 600% in 2021. It’s unrealistic to expect that the company will deliver that kind of performance in 2022. The company’s ability to pivot from a brick-and-mortar to a digital model has yet to be determined. But at this point, loyal GameStop investors believe in the stock, and that may be enough to push the stock higher.</p>\n<p><b>AMC Entertainment (AMC)</b></p>\n<p>When it comes to meme stocks, AMC Entertainment is the Robin to GameStop’s Batman. However, the AMC apes may say the opposite is true. It really doesn’t matter. What matters is that the committed AMC army has seen the stock post a 1,000% gain in 2021.</p>\n<p>The company is known for its chain of movie theatres. That was a troubled business model prior to the pandemic. However, as is the case with GameStop, the stock is not moving forward because investors are putting stock in the company’s current fundamentals; they have their eyes fixed on the future.</p>\n<p>Between AMC’s move into the non-fungible token (NFT) space and its willingness to accept some forms of cryptocurrency, the retail crowd believes there’s an emerging growth story for AMC stock.</p>\n<p>I don’t share that belief. Revenue for 2021 is expected to be about a billion dollars shy of where it was in 2019. Yet at this point in 2019, AMC stock was trading at around $8. As for 2022, the loyalty of retail investors could prop up the stock for some time to come. However, like GameStop, conservative investors should stay far away.</p>\n<p><b>BlackBerry (BB)</b></p>\n<p>BlackBerry may be best known to some people as the manufacturer of the mobile phone of the same name. And while some people may long to have their BlackBerry, the larger story of the company had to do with the safety and security that was built into the product. That’s because BlackBerry is, at its core, a software company.</p>\n<p>And that’s why, if you’re looking to buy the stock in 2022, you’ll want to look at their cybersecurity offerings that currently accounts for approximately two-thirds of BlackBerry’s revenue.</p>\n<p>There is some sentiment that BlackBerry is an acquisition target. However, the reason to buy BB stock is for its strategic partnerships with <b>Microsoft</b>(NASDAQ:<b><u>MSFT</u></b>) and Amazon. The latter is the most intriguing because it will allow BlackBerry’s Intelligent Vehicle Data Platform (IVY) to provide a consistent and secure common app that can be used for autonomous driving.</p>\n<p>Although the autonomous vehicle (AV) future may be years away, if you believe in that future, a small, speculative position in BB stock may pay off in the long run.</p>\n<p><b>Clover Health (CLOV)</b></p>\n<p>Like many companies on this list, the risk/reward calculus for Clover Health in 2022 comes down to its ability to generate revenue with its Clover Assistant. The Clover Assistant uses AI and predictive analysis to give doctors actionable patient care information that will drive better health outcomes.</p>\n<p>The bullish case says that by focusing on Medicare Advantage patients, Clover Health has a huge addressable market. The flipside to that argument is that many doctors the company is targeting don’t have that many Medicare Advantage patients.</p>\n<p>And, because of the regulatory environment that surrounds Medicate Advantage, it may not be as profitable as expected. One way that the company may look to address this is by opening up the Clover Assistant to fee-for-service Medicare patients.</p>\n<p>With that said, CLOV stock does have a $9 price target from the analyst community, which suggests that risk-tolerant investors may be rewarded for their investment.</p>\n<p><b>Zomedica (ZOM)</b></p>\n<p>I’ve followed Zomedica for most of 2021 and thought it was miscast as a meme stock. But the stock chart says it all. ZOM stock was literally a penny stock in December 2020. But in the first two months of 2021, it soared to over $2 a share. It’s since fallen back and is now back in penny stock territory.</p>\n<p>The story of Zomedica will come down to the acceptance of its Truforma product. This allows veterinarians to run diagnostic tests in their offices that they currently would have to send to an outside lab at additional time and expense. The company has launched a Customer Appreciation Program that will seed the product in veterinarian offices at no cost. The catalyst is that the offices make an agreement to buy the assays that are required to run the diagnostic tests directly from Zomedica.</p>\n<p>The company also recently acquired PulseVet, which gives the company another revenue-generation opportunity for the company that should start contributing to the company’s revenue in the next few quarters.</p>\n<p><b>Sundial Growers (SNDL)</b></p>\n<p>The cannabis sector continues to draw speculative interest, although profitability still seems to be years away. And Sundial Growers remains one of the most volatile stocks in the sector.</p>\n<p>If you’re going to invest in SNDL stock in 2022, you have to be convinced that their business model will work. But before you answer that question, you have to buy into what that business model is. It appears that the most profitable path is if the company can benefit from its affiliate filing an application to be a Business Development Company (BDC).</p>\n<p>This would seem like a better option than trying to forge a path ahead as a cannabis retailer. That continues to be a difficult path for any cannabis company, particularly as legalization in the United States is likely going to take longer than expected.</p>\n<p><b>Bed Bath & Beyond (BBBY)</b></p>\n<p>Bed Bath & Beyond is a curious case among the meme stocks. I can’t say the company is doing anything definitively wrong. But it’s also not doing anything that justifies a stock price that at one point was over $35 a share in 2021.</p>\n<p>That’s why it’s part of this meme stock list, because retail investors have figured out a formula and they’re making it work. Still, you have to be careful with your expectations. The company’s revenue and earnings are still down from pre-pandemic levels and yet the stock price is above pre-pandemic levels.</p>\n<p>The company recently announced a partnership with <b>Kroger</b>(NYSE:<b><u>KR</u></b>) that got some investors excited. However, it doesn’t appear to be a move that will be noticeable to the bottom line for several quarters, if ever.</p>\n<p>Bed Bath & Beyond is making some moves to close underperforming stores and introduce private-label brands. But it’s unclear how much playing defense will be able to help, which makes BBBY stock a risky option in 2022.</p>\n<p><b>Tesla (TSLA)</b></p>\n<p>Before meme stocks were a thing, there was Tesla. And one thing you can say about owning TSLA is that there’s never a dull moment. After the stock climbed to over $1,200 a share this year, it’s down to around $930, and that still has rewarded investors to the tune of a 32% gain for the year.</p>\n<p>I’ve long felt that TSLA stock is valued the way it is because investors view it as a technology play more than an electric vehicle (EV) play. However, it would seem that the company’s immediate fortunes will depend on its EV business, which should be a catalyst in 2022.</p>\n<p>Faisal Humayun recently wrote, Tesla plans to launch a $25,000 fully autonomous electric vehicle. That would be a clear game changer in terms of market share. And with $16.1 billion of cash on hand, the company has the balance sheet to invest in future expansion and innovation.</p>\n<p><b>ContextLogic (WISH)</b></p>\n<p>The only words I can offer to those looking to invest in ContextLogic is let the buyer beware. I can’t say the company isn’t trying to improve its financial situation. But the long-term outlook for WISH stock is troubled. And it’s unclear what the sales outlook is. Plus, the company’s founder and chief executive officer (CEO) announced he will be stepping aside as soon as a replacement is found.</p>\n<p>On the other hand, if you’re a believer in the speculative nature of the meme stock movement, then there are few stocks that bear it out more than WISH stock. The stock continues to be propped up by retail investors. And the analyst community gives the company a share price of over $11. That’s a gain of over 250% from its current price.</p>\n<p>But short interest remains high. And if you’re looking to open a position on WISH stock, you may want to wait until the outlook becomes clear.</p>\n<p><b>XPresSpa (XSPA)</b></p>\n<p>I have to admit, if someone had told me there was a business case for XpresSpa Group in 2022, I would have been skeptical. And while I won’t be buying XSPA stock anytime soon, I’ll let you decide for yourself.</p>\n<p>For those who are unfamiliar, the company has two business units. Its namesake unit, XpresSpa, offers premium spa services and “exclusive travel products and accessories through partnership with some of the leading cosmetics brands in the world.”</p>\n<p>However, with the collapse of travel during the Covid-19 pandemic, the company made a strategic pivot to turn their existing facilities into Covid-19 testing facilities. The idea was to have a location for airline crews and passengers to get fast, convenient testing at the airport.</p>\n<p>And as the pandemic remains in the public consciousness, rapid testing will remain a viable option, particularly as a significant segment of the population remains unvaccinated. However, it’s fair to question how much revenue the company can generate from this model. The company was continuing to lose money so it’s certainly not enough to be profitable.</p>\n<p>And with the company losing money prior to the pandemic in its prior business model, this is still a speculative bet.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top 10 Meme Stocks of 2021 and How They’ll Fare in 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop 10 Meme Stocks of 2021 and How They’ll Fare in 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-17 10:56 GMT+8 <a href=https://investorplace.com/2021/12/top-10-meme-stocks-and-how-they-fare-in-2022/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It's time to decide which of these meme stocks are good investments\nSource: Michael Vi / Shutterstock.com\nWe’re past the point of denial about meme stocks. What looked unsustainable nine months ago is...</p>\n\n<a href=\"https://investorplace.com/2021/12/top-10-meme-stocks-and-how-they-fare-in-2022/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMC":"AMC院线","CLOV":"Clover Health Corp","TSLA":"特斯拉","BBBY":"3B家居","GME":"游戏驿站","SNDL":"SNDL Inc.","BB":"黑莓"},"source_url":"https://investorplace.com/2021/12/top-10-meme-stocks-and-how-they-fare-in-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1162808117","content_text":"It's time to decide which of these meme stocks are good investments\nSource: Michael Vi / Shutterstock.com\nWe’re past the point of denial about meme stocks. What looked unsustainable nine months ago is proving to have staying power. Retail investors continue to identify their favorite stocks and drive up the price.\nThe bullish case for meme stocks says that retail investors, with more research available to them than ever before, are willing to take a risk on companies that may be the next Amazon(NASDAQ:AMZN). The bearish case is that they may be propping up companies that deserve to trade for much, much lower.\nWho’s to say which side is right? I tend to believe that some of the moral outrage being expressed by retail investors against hedge funds is a rationale to avoid admitting that they’re investment strategy is similar to gambling. But there are many things in life that are a gamble and it’s not my money.\nThat argument will continue to play out in 2022. So it may be interesting to look at 10 meme stocks that have been part of the this movement in 2021. And it’s also time to take a look at how these stocks may fare in 2022.\n\nGameStop(NYSE:GME)\nAMC Entertainment(NYSE:AMC)\nBlackBerry(NYSE:BB)\nClover Health(NASDAQ:CLOV)\nZomedica(NYSE:ZOM)\nSundial Growers(NASDAQ:SNDL)\nBed Bath & Beyond(NASDAQ:BBBY)\nTesla(NASDAQ:TSLA)\nContextLogic(NASDAQ:WISH)\nXPresSpa(NASDAQ:XSPA)\n\nGameStop (GME)\nGameStop is the company that made the terms “meme stocks” and “short squeeze” household names. The initial surge in GME stock was caused by retail investors who identified a high level of short interest in the stock. This led to the short squeeze to end all short squeezes. GameStop stock moved from $17.25 to a closing price of $347.51 in late January.\nHowever, a recent report from the Securities & Exchange Commission(SEC) confirms that the rise in the GME stock price was largely due to retail investors continuing to bid the stock higher, not as much short sellers covering their position.\nNeedless to say, the stock price wasn’t sustainable, but GME stock is still up over 600% in 2021. It’s unrealistic to expect that the company will deliver that kind of performance in 2022. The company’s ability to pivot from a brick-and-mortar to a digital model has yet to be determined. But at this point, loyal GameStop investors believe in the stock, and that may be enough to push the stock higher.\nAMC Entertainment (AMC)\nWhen it comes to meme stocks, AMC Entertainment is the Robin to GameStop’s Batman. However, the AMC apes may say the opposite is true. It really doesn’t matter. What matters is that the committed AMC army has seen the stock post a 1,000% gain in 2021.\nThe company is known for its chain of movie theatres. That was a troubled business model prior to the pandemic. However, as is the case with GameStop, the stock is not moving forward because investors are putting stock in the company’s current fundamentals; they have their eyes fixed on the future.\nBetween AMC’s move into the non-fungible token (NFT) space and its willingness to accept some forms of cryptocurrency, the retail crowd believes there’s an emerging growth story for AMC stock.\nI don’t share that belief. Revenue for 2021 is expected to be about a billion dollars shy of where it was in 2019. Yet at this point in 2019, AMC stock was trading at around $8. As for 2022, the loyalty of retail investors could prop up the stock for some time to come. However, like GameStop, conservative investors should stay far away.\nBlackBerry (BB)\nBlackBerry may be best known to some people as the manufacturer of the mobile phone of the same name. And while some people may long to have their BlackBerry, the larger story of the company had to do with the safety and security that was built into the product. That’s because BlackBerry is, at its core, a software company.\nAnd that’s why, if you’re looking to buy the stock in 2022, you’ll want to look at their cybersecurity offerings that currently accounts for approximately two-thirds of BlackBerry’s revenue.\nThere is some sentiment that BlackBerry is an acquisition target. However, the reason to buy BB stock is for its strategic partnerships with Microsoft(NASDAQ:MSFT) and Amazon. The latter is the most intriguing because it will allow BlackBerry’s Intelligent Vehicle Data Platform (IVY) to provide a consistent and secure common app that can be used for autonomous driving.\nAlthough the autonomous vehicle (AV) future may be years away, if you believe in that future, a small, speculative position in BB stock may pay off in the long run.\nClover Health (CLOV)\nLike many companies on this list, the risk/reward calculus for Clover Health in 2022 comes down to its ability to generate revenue with its Clover Assistant. The Clover Assistant uses AI and predictive analysis to give doctors actionable patient care information that will drive better health outcomes.\nThe bullish case says that by focusing on Medicare Advantage patients, Clover Health has a huge addressable market. The flipside to that argument is that many doctors the company is targeting don’t have that many Medicare Advantage patients.\nAnd, because of the regulatory environment that surrounds Medicate Advantage, it may not be as profitable as expected. One way that the company may look to address this is by opening up the Clover Assistant to fee-for-service Medicare patients.\nWith that said, CLOV stock does have a $9 price target from the analyst community, which suggests that risk-tolerant investors may be rewarded for their investment.\nZomedica (ZOM)\nI’ve followed Zomedica for most of 2021 and thought it was miscast as a meme stock. But the stock chart says it all. ZOM stock was literally a penny stock in December 2020. But in the first two months of 2021, it soared to over $2 a share. It’s since fallen back and is now back in penny stock territory.\nThe story of Zomedica will come down to the acceptance of its Truforma product. This allows veterinarians to run diagnostic tests in their offices that they currently would have to send to an outside lab at additional time and expense. The company has launched a Customer Appreciation Program that will seed the product in veterinarian offices at no cost. The catalyst is that the offices make an agreement to buy the assays that are required to run the diagnostic tests directly from Zomedica.\nThe company also recently acquired PulseVet, which gives the company another revenue-generation opportunity for the company that should start contributing to the company’s revenue in the next few quarters.\nSundial Growers (SNDL)\nThe cannabis sector continues to draw speculative interest, although profitability still seems to be years away. And Sundial Growers remains one of the most volatile stocks in the sector.\nIf you’re going to invest in SNDL stock in 2022, you have to be convinced that their business model will work. But before you answer that question, you have to buy into what that business model is. It appears that the most profitable path is if the company can benefit from its affiliate filing an application to be a Business Development Company (BDC).\nThis would seem like a better option than trying to forge a path ahead as a cannabis retailer. That continues to be a difficult path for any cannabis company, particularly as legalization in the United States is likely going to take longer than expected.\nBed Bath & Beyond (BBBY)\nBed Bath & Beyond is a curious case among the meme stocks. I can’t say the company is doing anything definitively wrong. But it’s also not doing anything that justifies a stock price that at one point was over $35 a share in 2021.\nThat’s why it’s part of this meme stock list, because retail investors have figured out a formula and they’re making it work. Still, you have to be careful with your expectations. The company’s revenue and earnings are still down from pre-pandemic levels and yet the stock price is above pre-pandemic levels.\nThe company recently announced a partnership with Kroger(NYSE:KR) that got some investors excited. However, it doesn’t appear to be a move that will be noticeable to the bottom line for several quarters, if ever.\nBed Bath & Beyond is making some moves to close underperforming stores and introduce private-label brands. But it’s unclear how much playing defense will be able to help, which makes BBBY stock a risky option in 2022.\nTesla (TSLA)\nBefore meme stocks were a thing, there was Tesla. And one thing you can say about owning TSLA is that there’s never a dull moment. After the stock climbed to over $1,200 a share this year, it’s down to around $930, and that still has rewarded investors to the tune of a 32% gain for the year.\nI’ve long felt that TSLA stock is valued the way it is because investors view it as a technology play more than an electric vehicle (EV) play. However, it would seem that the company’s immediate fortunes will depend on its EV business, which should be a catalyst in 2022.\nFaisal Humayun recently wrote, Tesla plans to launch a $25,000 fully autonomous electric vehicle. That would be a clear game changer in terms of market share. And with $16.1 billion of cash on hand, the company has the balance sheet to invest in future expansion and innovation.\nContextLogic (WISH)\nThe only words I can offer to those looking to invest in ContextLogic is let the buyer beware. I can’t say the company isn’t trying to improve its financial situation. But the long-term outlook for WISH stock is troubled. And it’s unclear what the sales outlook is. Plus, the company’s founder and chief executive officer (CEO) announced he will be stepping aside as soon as a replacement is found.\nOn the other hand, if you’re a believer in the speculative nature of the meme stock movement, then there are few stocks that bear it out more than WISH stock. The stock continues to be propped up by retail investors. And the analyst community gives the company a share price of over $11. That’s a gain of over 250% from its current price.\nBut short interest remains high. And if you’re looking to open a position on WISH stock, you may want to wait until the outlook becomes clear.\nXPresSpa (XSPA)\nI have to admit, if someone had told me there was a business case for XpresSpa Group in 2022, I would have been skeptical. And while I won’t be buying XSPA stock anytime soon, I’ll let you decide for yourself.\nFor those who are unfamiliar, the company has two business units. Its namesake unit, XpresSpa, offers premium spa services and “exclusive travel products and accessories through partnership with some of the leading cosmetics brands in the world.”\nHowever, with the collapse of travel during the Covid-19 pandemic, the company made a strategic pivot to turn their existing facilities into Covid-19 testing facilities. The idea was to have a location for airline crews and passengers to get fast, convenient testing at the airport.\nAnd as the pandemic remains in the public consciousness, rapid testing will remain a viable option, particularly as a significant segment of the population remains unvaccinated. However, it’s fair to question how much revenue the company can generate from this model. The company was continuing to lose money so it’s certainly not enough to be profitable.\nAnd with the company losing money prior to the pandemic in its prior business model, this is still a speculative bet.","news_type":1,"symbols_score_info":{"AMC":0.9,"BB":0.9,"BBBY":0.9,"CLOV":0.9,"GME":0.9,"SNDL":0.9,"TSLA":0.9,"WISH":0.9,"XSPA":0.9,"ZOM":0.9}},"isVote":1,"tweetType":1,"viewCount":2462,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690284516,"gmtCreate":1639669967578,"gmtModify":1639669968054,"author":{"id":"3576212227172632","authorId":"3576212227172632","name":"ToTheMOON","avatar":"https://static.tigerbbs.com/7769f4b8d26aa1903d8784e79b05b4df","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576212227172632","authorIdStr":"3576212227172632"},"themes":[],"htmlText":"I just bought ","listText":"I just bought ","text":"I just bought","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/690284516","repostId":"2191453039","repostType":4,"isVote":1,"tweetType":1,"viewCount":1681,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690284886,"gmtCreate":1639669952874,"gmtModify":1639669953347,"author":{"id":"3576212227172632","authorId":"3576212227172632","name":"ToTheMOON","avatar":"https://static.tigerbbs.com/7769f4b8d26aa1903d8784e79b05b4df","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576212227172632","authorIdStr":"3576212227172632"},"themes":[],"htmlText":"Yup lol 😂 ","listText":"Yup lol 😂 ","text":"Yup lol 😂","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690284886","repostId":"1100303965","repostType":4,"repost":{"id":"1100303965","kind":"news","pubTimestamp":1639661353,"share":"https://www.laohu8.com/m/news/1100303965?lang=&edition=full","pubTime":"2021-12-16 21:29","market":"us","language":"en","title":"Motional partners with Uber to provide autonomous food deliveries in California","url":"https://stock-news.laohu8.com/highlight/detail?id=1100303965","media":"Reuters","summary":"Motional, the self-driving joint venture of Hyundai Motor Co and Aptiv PLC, on Thursday said it was ","content":"<p>Motional, the self-driving joint venture of Hyundai Motor Co and Aptiv PLC, on Thursday said it was entering the autonomous delivery market by providing meal kits for some California Uber Technologies Inc customers.</p>\n<p>Motional said it would start delivering meals from select restaurants on Uber's food delivery app Eats in Santa Monica in early 2022.</p>\n<p>The companies did not say whether the partnership would be expanded to other locations. But Motional President and Chief Executive Karl Iagnemma in a statement said the joint-venture was seeing \"many long-term opportunities for further deploying Motional's technology across the Uber platform.\"</p>\n<p>The deliveries will be made in Hyundai's fully electric IONIQ-5 vehicles, converted to operate autonomously. A spokesperson said a safety driver will be present inside the vehicles.</p>\n<p>Asked whether Uber Eats customers would have to walk to the vehicles to accept their meal orders, the spokesperson said the companies would share more details on the service ahead of the launch.</p>\n<p>Motional's pivot to food delivery follows a move by many companies in the self-driving industry to expand from their original ambition of providing a consumer robotaxi services.</p>\n<p>Self-driving companies have repeatedly pushed out timelines to provide truly driverless rides, with only a few limited fully autonomous programs available across the U.S.</p>\n<p>Automating the delivery of goods in less challenging environments, such as suburbs or along highway stretches, is offering a faster way to generate returns.</p>\n<p>Motional has been operating a robotaxi pilot program in Las Vegas with U.S. Uber rival Lyft Inc over the last three years. Motional and Lyft in November said they will launch a fully driverless ride-hail service in Las Vegas in 2023.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Motional partners with Uber to provide autonomous food deliveries in California</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMotional partners with Uber to provide autonomous food deliveries in California\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-16 21:29 GMT+8 <a href=https://finance.yahoo.com/news/motional-partners-uber-autonomous-food-130910821.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Motional, the self-driving joint venture of Hyundai Motor Co and Aptiv PLC, on Thursday said it was entering the autonomous delivery market by providing meal kits for some California Uber Technologies...</p>\n\n<a href=\"https://finance.yahoo.com/news/motional-partners-uber-autonomous-food-130910821.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UBER":"优步"},"source_url":"https://finance.yahoo.com/news/motional-partners-uber-autonomous-food-130910821.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1100303965","content_text":"Motional, the self-driving joint venture of Hyundai Motor Co and Aptiv PLC, on Thursday said it was entering the autonomous delivery market by providing meal kits for some California Uber Technologies Inc customers.\nMotional said it would start delivering meals from select restaurants on Uber's food delivery app Eats in Santa Monica in early 2022.\nThe companies did not say whether the partnership would be expanded to other locations. But Motional President and Chief Executive Karl Iagnemma in a statement said the joint-venture was seeing \"many long-term opportunities for further deploying Motional's technology across the Uber platform.\"\nThe deliveries will be made in Hyundai's fully electric IONIQ-5 vehicles, converted to operate autonomously. A spokesperson said a safety driver will be present inside the vehicles.\nAsked whether Uber Eats customers would have to walk to the vehicles to accept their meal orders, the spokesperson said the companies would share more details on the service ahead of the launch.\nMotional's pivot to food delivery follows a move by many companies in the self-driving industry to expand from their original ambition of providing a consumer robotaxi services.\nSelf-driving companies have repeatedly pushed out timelines to provide truly driverless rides, with only a few limited fully autonomous programs available across the U.S.\nAutomating the delivery of goods in less challenging environments, such as suburbs or along highway stretches, is offering a faster way to generate returns.\nMotional has been operating a robotaxi pilot program in Las Vegas with U.S. Uber rival Lyft Inc over the last three years. Motional and Lyft in November said they will launch a fully driverless ride-hail service in Las Vegas in 2023.","news_type":1,"symbols_score_info":{"UBER":0.9}},"isVote":1,"tweetType":1,"viewCount":1960,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690282005,"gmtCreate":1639669814094,"gmtModify":1639669814565,"author":{"id":"3576212227172632","authorId":"3576212227172632","name":"ToTheMOON","avatar":"https://static.tigerbbs.com/7769f4b8d26aa1903d8784e79b05b4df","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576212227172632","authorIdStr":"3576212227172632"},"themes":[],"htmlText":"Yup lol 😂 is it ok to ","listText":"Yup lol 😂 is it ok to ","text":"Yup lol 😂 is it ok to","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690282005","repostId":"1195807724","repostType":4,"repost":{"id":"1195807724","kind":"news","pubTimestamp":1639666797,"share":"https://www.laohu8.com/m/news/1195807724?lang=&edition=full","pubTime":"2021-12-16 22:59","market":"us","language":"en","title":"U.S. manufacturing activity slows; factory supply constraints easing - IHS Markit survey","url":"https://stock-news.laohu8.com/highlight/detail?id=1195807724","media":"Reuters","summary":"U.S. manufacturing activity slowed to a one-year low in December, but there are signs that labor and","content":"<p>U.S. manufacturing activity slowed to a one-year low in December, but there are signs that labor and raw material supply constraints at factories are starting to ease.</p>\n<p>Data firm IHS Markit said on Thursday that its flash manufacturing PMI fell to a reading of 57.8 in mid-December from 58.3 in November. That was the lowest since December 2020. A reading above 50 indicates expansion in the manufacturing sector, which accounts for 12% of the economy. Economists had forecast the flash PMI climbing to 58.5.</p>\n<p>Manufacturing remains underpinned by strong demand for goods and extremely lean inventories at businesses. But strained supply chains because of the COVID-19 pandemic are a constrain.</p>\n<p>There are glimmers of hope, however. The survey showed \"supply chain delays moderating markedly during the month,\" and \"the rate of job creation quickened to the fastest since June.\" It also noted that \"the rate of cost inflation softened to the slowest for seven months.\"</p>\n<p>But shortages remained binding for the vast services sector. The survey's flash services sector PMI dipped to a reading of 57.5 from 58.0 in November. Economists polled by Reuters had forecast a reading of 58.5 for the services sector, which accounts for more than two-thirds of U.S. economic activity.</p>\n<p>A measure of services sector input prices rose to 77.4, the highest since the series started in 2009, from 75.7 in November. That is a potential sign that inflation could remain significantly high for a while. Consumer prices increased by the most since 1982 on a year-on-year basis in November.</p>\n<p>With both manufacturing and services sectors activity slowing, overall business activity cooled this month. The survey's flash Composite PMI Output Index fell to a reading of 56.9 from 57.2 in November.</p>\n<p>Its measure of prices paid by businesses for inputs climbed to 78.1. That was the highest reading since the series started in 2009 and followed 77.6 in November.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. manufacturing activity slows; factory supply constraints easing - IHS Markit survey</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. manufacturing activity slows; factory supply constraints easing - IHS Markit survey\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-16 22:59 GMT+8 <a href=https://finance.yahoo.com/news/u-manufacturing-activity-slows-factory-145248409.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>U.S. manufacturing activity slowed to a one-year low in December, but there are signs that labor and raw material supply constraints at factories are starting to ease.\nData firm IHS Markit said on ...</p>\n\n<a href=\"https://finance.yahoo.com/news/u-manufacturing-activity-slows-factory-145248409.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://finance.yahoo.com/news/u-manufacturing-activity-slows-factory-145248409.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1195807724","content_text":"U.S. manufacturing activity slowed to a one-year low in December, but there are signs that labor and raw material supply constraints at factories are starting to ease.\nData firm IHS Markit said on Thursday that its flash manufacturing PMI fell to a reading of 57.8 in mid-December from 58.3 in November. That was the lowest since December 2020. A reading above 50 indicates expansion in the manufacturing sector, which accounts for 12% of the economy. Economists had forecast the flash PMI climbing to 58.5.\nManufacturing remains underpinned by strong demand for goods and extremely lean inventories at businesses. But strained supply chains because of the COVID-19 pandemic are a constrain.\nThere are glimmers of hope, however. The survey showed \"supply chain delays moderating markedly during the month,\" and \"the rate of job creation quickened to the fastest since June.\" It also noted that \"the rate of cost inflation softened to the slowest for seven months.\"\nBut shortages remained binding for the vast services sector. The survey's flash services sector PMI dipped to a reading of 57.5 from 58.0 in November. Economists polled by Reuters had forecast a reading of 58.5 for the services sector, which accounts for more than two-thirds of U.S. economic activity.\nA measure of services sector input prices rose to 77.4, the highest since the series started in 2009, from 75.7 in November. That is a potential sign that inflation could remain significantly high for a while. Consumer prices increased by the most since 1982 on a year-on-year basis in November.\nWith both manufacturing and services sectors activity slowing, overall business activity cooled this month. The survey's flash Composite PMI Output Index fell to a reading of 56.9 from 57.2 in November.\nIts measure of prices paid by businesses for inputs climbed to 78.1. That was the highest reading since the series started in 2009 and followed 77.6 in November.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":1535,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607809488,"gmtCreate":1639520679195,"gmtModify":1639520679745,"author":{"id":"3576212227172632","authorId":"3576212227172632","name":"ToTheMOON","avatar":"https://static.tigerbbs.com/7769f4b8d26aa1903d8784e79b05b4df","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576212227172632","authorIdStr":"3576212227172632"},"themes":[],"htmlText":"You can only buy a new version ","listText":"You can only buy a new version ","text":"You can only buy a new version","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/607809488","repostId":"1155236279","repostType":4,"isVote":1,"tweetType":1,"viewCount":1667,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604657884,"gmtCreate":1639392421908,"gmtModify":1639393027357,"author":{"id":"3576212227172632","authorId":"3576212227172632","name":"ToTheMOON","avatar":"https://static.tigerbbs.com/7769f4b8d26aa1903d8784e79b05b4df","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576212227172632","authorIdStr":"3576212227172632"},"themes":[],"htmlText":"Yup lol I got it ","listText":"Yup lol I got it ","text":"Yup lol I got it","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604657884","repostId":"1199964643","repostType":4,"repost":{"id":"1199964643","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639387887,"share":"https://www.laohu8.com/m/news/1199964643?lang=&edition=full","pubTime":"2021-12-13 17:31","market":"us","language":"en","title":"Petros Pharmaceuticals soared nearly 50% in premarket trading as it reported positive label comprehension results for Stendra","url":"https://stock-news.laohu8.com/highlight/detail?id=1199964643","media":"Tiger Newspress","summary":"Petros Pharmaceuticals soared nearly 50% in premarket trading as it reported positive label comprehe","content":"<p>Petros Pharmaceuticals soared nearly 50% in premarket trading as it reported positive label comprehension results for Stendra.<img src=\"https://static.tigerbbs.com/7fb0701575bb0a522dfaad7f6d8c21b4\" tg-width=\"772\" tg-height=\"564\" width=\"100%\" height=\"auto\">The company reported positive over-the-counter (OTC) draft label comprehension study results for its erectile dysfunction (ED) Drug STENDRA®(avanafil). </p>\n<p>This Pivotal Label Comprehension Study was designed to assess comprehension of a draft STENDRA®Drug Facts Label intended for OTC use. This study was a key component in the Company's plans to engage in discussions with the FDA to expand the product's access through application for a possible OTC pathway. </p>\n<p>Early study indicators showed positive label comprehension outcomes in the study, which had encouraged the Company to initiate the next step, a Self-Selection Study, as it continued to build the case for the FDA for OTC access to STENDRA.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Petros Pharmaceuticals soared nearly 50% in premarket trading as it reported positive label comprehension results for Stendra</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPetros Pharmaceuticals soared nearly 50% in premarket trading as it reported positive label comprehension results for Stendra\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-13 17:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Petros Pharmaceuticals soared nearly 50% in premarket trading as it reported positive label comprehension results for Stendra.<img src=\"https://static.tigerbbs.com/7fb0701575bb0a522dfaad7f6d8c21b4\" tg-width=\"772\" tg-height=\"564\" width=\"100%\" height=\"auto\">The company reported positive over-the-counter (OTC) draft label comprehension study results for its erectile dysfunction (ED) Drug STENDRA®(avanafil). </p>\n<p>This Pivotal Label Comprehension Study was designed to assess comprehension of a draft STENDRA®Drug Facts Label intended for OTC use. This study was a key component in the Company's plans to engage in discussions with the FDA to expand the product's access through application for a possible OTC pathway. </p>\n<p>Early study indicators showed positive label comprehension outcomes in the study, which had encouraged the Company to initiate the next step, a Self-Selection Study, as it continued to build the case for the FDA for OTC access to STENDRA.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1199964643","content_text":"Petros Pharmaceuticals soared nearly 50% in premarket trading as it reported positive label comprehension results for Stendra.The company reported positive over-the-counter (OTC) draft label comprehension study results for its erectile dysfunction (ED) Drug STENDRA®(avanafil). \nThis Pivotal Label Comprehension Study was designed to assess comprehension of a draft STENDRA®Drug Facts Label intended for OTC use. This study was a key component in the Company's plans to engage in discussions with the FDA to expand the product's access through application for a possible OTC pathway. \nEarly study indicators showed positive label comprehension outcomes in the study, which had encouraged the Company to initiate the next step, a Self-Selection Study, as it continued to build the case for the FDA for OTC access to STENDRA.","news_type":1,"symbols_score_info":{"PTPI":0.9}},"isVote":1,"tweetType":1,"viewCount":1565,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605713866,"gmtCreate":1639261210971,"gmtModify":1639261213869,"author":{"id":"3576212227172632","authorId":"3576212227172632","name":"ToTheMOON","avatar":"https://static.tigerbbs.com/7769f4b8d26aa1903d8784e79b05b4df","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576212227172632","authorIdStr":"3576212227172632"},"themes":[],"htmlText":"Yup lol lol haha I was thinking 🤔 ","listText":"Yup lol lol haha I was thinking 🤔 ","text":"Yup lol lol haha I was thinking 🤔","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/605713866","repostId":"2190484675","repostType":4,"isVote":1,"tweetType":1,"viewCount":1791,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605526039,"gmtCreate":1639194343111,"gmtModify":1639194343606,"author":{"id":"3576212227172632","authorId":"3576212227172632","name":"ToTheMOON","avatar":"https://static.tigerbbs.com/7769f4b8d26aa1903d8784e79b05b4df","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576212227172632","authorIdStr":"3576212227172632"},"themes":[],"htmlText":"Use my phone for every one ☝️ ","listText":"Use my phone for every one ☝️ ","text":"Use my phone for every one ☝️","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/605526039","repostId":"2190205546","repostType":4,"isVote":1,"tweetType":1,"viewCount":2382,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"followers","isTTM":false}